Federal Policy
6Federal Policy·6:01 AM MT
CMS issued the CY 2027 Physician Fee Schedule Proposed Rule limiting remote patient monitoring and remote therapeutic monitoring services. The proposal restricts outsourced clinical staffing, imposes new billing requirements, and reduces reimbursement for certain services. Changes would take effect January 1, 2027. The restrictions reverse CMS's 2025 expansion of RPM/RTM access and could significantly affect Medicaid managed care organizations and providers using remote monitoring for chronic condition management, particularly for dialysis and other high-cost populations.
Why it mattersMedicaid managed care plans using remote patient monitoring for care management — especially for ESRD, diabetes, and other chronic conditions — face potential operational disruption and reduced federal reimbursement if states align Medicaid policies with Medicare fee schedule changes.
Federal Policy·12:00 PM MT
CMS released a proposed 2027 outpatient payment rule on July 2, 2026, that would cut billions from 340B drug payments and expand site-neutral payment policies affecting hospital reimbursement. The rule compounds financial pressure on hospitals already facing margin challenges, combining payment reductions that hospital finance leaders have previously fought separately. Comments on the proposed rule are due under the standard federal rulemaking timeline, typically 60 days from publication. The combined effect threatens Medicaid DSH hospitals and safety-net providers that rely heavily on 340B revenue and outpatient volume.
Why it mattersState Medicaid agencies and managed care plans should anticipate hospital network stability concerns and potential provider terminations if safety-net hospitals face simultaneous 340B cuts, site-neutral reimbursement expansion, and state Medicaid rate pressure.
Federal Policy·6:00 AM MT
Following changes to federal vaccine recommendations under the Trump administration, pediatricians and state health departments report they can no longer rely on CDC guidance as a trusted resource for families. Some providers are developing their own vaccine schedules and educational materials. The shift affects Medicaid-enrolled children, who comprise approximately 40% of the pediatric population and depend on EPSDT-mandated preventive services including immunizations. State Medicaid agencies may face inconsistent vaccine coverage determinations if provider guidance diverges from federal standards.
Why it mattersDivergent vaccine guidance could create coverage gaps and payment disputes for EPSDT-required immunizations, particularly if state Medicaid agencies continue following federal schedules while network providers adopt alternative protocols.
Federal Policy·2:06 PM MT
On July 31, 2026, CMS issued the FY 2027 Inpatient Prospective Payment System (IPPS) final rule. The rule sets Medicare payment rates and policies for inpatient hospital services for the fiscal year beginning October 1, 2026. While the IPPS primarily governs Medicare payments, the rule's rate methodologies and quality measures often influence Medicaid supplemental payment programs, state upper payment limit calculations, and hospital financial stability that affects Medicaid providers. The rule takes effect October 1, 2026.
Why it mattersHospital payment rate changes under Medicare IPPS often serve as benchmarks for Medicaid supplemental payments and affect the financial condition of dual-eligible serving hospitals.
Federal Policy·12:00 PM MT
An international expert panel published systematic review and consensus guidelines on incretin-based medications (GLP-1s including semaglutide, liraglutide, dulaglutide, exenatide) in women's reproductive health, covering use before, during, and after pregnancy. The guidance, published in Obesity Reviews and based on 34 studies, provides counseling recommendations for clinicians treating patients on these medications. The guidelines address an emerging clinical question as GLP-1 use expands among women of reproductive age, including Medicaid beneficiaries with obesity and diabetes.
Why it mattersMedicaid covers approximately 42% of births nationally and serves high rates of women with obesity and diabetes who may be prescribed GLP-1s, making clinical guidance on pregnancy safety and medication management directly relevant to state prenatal care protocols and managed care quality measures.
Federal Policy·6:00 AM MT
CMS is re-establishing a Privacy Act matching program with the Department of War to verify minimum essential coverage under the Affordable Care Act through War Department health benefit plans. The matching program allows CMS to cross-reference enrollment data to confirm ACA coverage requirements are met. The notice was published August 5, 2026, under Privacy Act requirements. This routine administrative action maintains existing data-sharing arrangements between federal agencies for coverage verification purposes.
Why it mattersThe data match affects how CMS verifies continuous coverage for individuals with War Department health benefits, relevant for states coordinating Medicaid eligibility determinations with other minimum essential coverage sources.
Managed Care
2Managed Care·6:00 AM MT
UnitedHealthcare will implement new reimbursement limits on five categories of lab tests — allergen testing, liver fibrosis testing, in vitro chemotherapy sensitivity assays, testosterone blood tests, and vitamin B12 testing — effective September 1, 2026. The policies apply across the company's commercial, ACA exchange, Medicare Advantage, and Medicaid product lines. UnitedHealthcare Medicaid plans will be affected by the same utilization management criteria being applied to other lines of business. The changes will affect laboratory providers billing UnitedHealthcare Medicaid plans and could impact member access to certain diagnostic tests.
Why it mattersState Medicaid agencies contracting with UnitedHealthcare MCOs should assess whether these reimbursement restrictions comply with state contract provisions on laboratory access and medical necessity criteria, particularly for populations with chronic conditions requiring routine lab monitoring.
Managed Care·MD·6:00 AM MT
Baltimore is creating a new 911 response service designed to address health crises before they escalate. The city will deploy alternative responders when people call 911 for certain health-related emergencies. The initiative aims to connect individuals to appropriate health services rather than traditional emergency response. For Medicaid managed care organizations and behavioral health providers, this represents a shift in crisis intervention that may affect emergency department utilization, care coordination requirements, and community-based crisis response networks.
Why it mattersThis alternative response model will require MCOs and behavioral health providers to coordinate with new city crisis responders and may reduce avoidable emergency department visits among Medicaid enrollees.
State Policy
4State Policy·NC·6:01 AM MT
A new study found that Medicaid expansion has not reduced firearm suicide rates among most men, despite documented improvements in health care access and behavioral health treatment availability for expansion populations. The research challenges assumptions about the relationship between Medicaid coverage and suicide prevention outcomes for male enrollees. The findings have implications for state Medicaid agencies and managed care organizations designing behavioral health interventions and measuring quality outcomes in expansion populations, particularly as states continue to evaluate the effectiveness of coverage expansions on mental health and mortality metrics.
Why it mattersStates and MCOs investing in behavioral health access under expansion may need to reconsider intervention strategies and outcome measures for male enrollees at risk of suicide, particularly regarding firearm-related prevention.
State Policy·CT·6:01 AM MT
Connecticut's Medicaid program is considering implementing restrictions on HIV medication access that would limit available treatment options for beneficiaries. The proposed limitations would affect patients currently receiving or seeking HIV treatment through the state's Medicaid program. The timing and specific scope of the restrictions under consideration have not been publicly detailed. This development raises concerns about medication continuity and treatment adherence for Connecticut Medicaid beneficiaries living with HIV, particularly given clinical evidence supporting treatment choice in managing the condition.
Why it mattersFormulary restrictions on HIV medications could disrupt established treatment regimens, potentially affecting viral suppression rates and health outcomes for Connecticut's Medicaid HIV-positive population while raising federal compliance questions under essential health benefit and medical necessity standards.
State Policy·IN·6:01 AM MT
Indiana will implement new Medicaid work requirements and eligibility rules over the next 18 months, following a redetermination period that already removed hundreds of thousands of beneficiaries from coverage. The changes represent a second phase of enrollment restrictions after the unwinding of pandemic-era continuous coverage protections. The new requirements will determine whether additional beneficiaries lose Medicaid coverage. State agencies and managed care plans operating in Indiana will need to adjust operations to support compliance tracking and member communications around the work requirement policy.
Why it mattersIndiana MCOs will need to build infrastructure for work requirement verification and develop retention strategies as enrollment declines threaten capitation revenue.
State Policy·6:00 AM MT
Multiple states are implementing new restrictions on Applied Behavior Analysis (ABA) therapy coverage for children with autism under Medicaid. The changes include stricter prior authorization requirements, reduced therapy hour caps, and new medical necessity criteria. State Medicaid agencies cite rising program costs and utilization management concerns as drivers for the policy shifts. The restrictions affect access to the primary evidence-based treatment for autism covered by Medicaid, which serves as the largest payer of autism services nationally.
Why it mattersABA therapy represents one of the highest-cost specialty services in pediatric Medicaid, and coverage restrictions will directly impact managed care organizations' network adequacy requirements, provider contracting, and appeals volume.
Legal
5Legal·PA·12:01 PM MT
The Department of Justice announced on August 4, 2026, the creation of a dedicated Medicaid fraud strike force in Philadelphia, expanding its Northeast Health Care Fraud Strike Force operations. The new unit will focus on investigating and prosecuting Medicaid fraud cases in the Philadelphia region. The announcement coincides with a parallel expansion of DOJ's West Coast Strike Force, signaling intensified federal enforcement activity targeting Medicaid program integrity. The move indicates heightened scrutiny of Medicaid providers, plans, and related entities operating in these regions.
Why it mattersThe new strike force signals increased federal enforcement risk for Medicaid providers and managed care organizations in Philadelphia, requiring heightened attention to compliance controls and internal audit functions.
Legal·ME·6:01 AM MT
The Maine Supreme Court ruled Tuesday in favor of the state's 10-year, $750 million Medicaid non-emergency transportation contract with Denver-based Modivcare, ending a legal challenge by nonprofit provider Penquis. The decision allows Maine DHHS to proceed with the statewide contract, consolidating NEMT services under a single vendor. The ruling resolves a multi-year procurement dispute and establishes the operational framework for Medicaid transportation services statewide. The contract represents one of the largest NEMT procurements nationally and affects transportation access for Maine's Medicaid beneficiaries.
Why it mattersThe ruling finalizes Maine's shift to a single statewide NEMT vendor, affecting how managed care plans and the state coordinate transportation benefits and potentially setting a precedent for other states considering NEMT consolidation.
Legal·PA·6:00 AM MT
The Department of Justice, in coordination with the U.S. Attorney's Office and Pennsylvania Attorney General, charged 19 defendants in a $4 million Medicare and Medicaid fraud scheme involving home health services. The alleged scheme included billing for services never rendered and submitting claims for unrealistic service hours. The charges were announced in early August 2026. The enforcement action signals continued federal and state scrutiny of home health billing practices, particularly phantom billing and time-based service inflation.
Why it mattersThe charges underscore heightened federal and state enforcement focus on home health fraud, requiring MCOs and providers to strengthen claims auditing and service verification controls to detect phantom billing and unrealistic time-based claims before submission.
Legal·12:01 PM MT
Following July 8 oral argument in City of Columbus v. Kennedy, challenging CMS's 2027 Notice of Benefit and Payment Parameters Final Rule, the U.S. District Court for the District of Maryland ordered supplemental briefs on implementation feasibility. The Court asked parties to address whether relief could be granted without disrupting the 2027 Marketplace plan year and whether staying catastrophic-plan guidance would affect enrollees. The case involves provisions of the NBPP final rule affecting Exchange operations. Supplemental briefing timing will determine how quickly the Court rules and whether any injunction could affect 2027 plan year implementation.
Why it mattersThe Court's feasibility questions signal potential relief may hinge on operational timing, with implications for state-based Exchange operations and catastrophic plan offerings for 2027 if the Court issues an injunction affecting the NBPP rule.
Legal·12:01 PM MT
Federal courts have issued several rulings favoring hospices in administrative appeals, particularly recognizing that hospices should receive deference when determining six-month life expectancy for patient eligibility. These rulings counter administrative law judge decisions that had reversed hospice eligibility determinations. The court decisions affect how hospices defend Medicare and Medicaid eligibility claims during audits and appeals. This development matters for hospices serving dual-eligible beneficiaries and state Medicaid programs that follow Medicare hospice coverage rules.
Why it mattersThese court rulings establish legal precedent that may reduce hospice claim denials and provide stronger grounds for appeals when state Medicaid programs or Medicare contractors challenge eligibility determinations for dual-eligible beneficiaries.